全球神经衰弱治疗市场 – 行业趋势及 2030 年预测

神经衰弱治疗市场分析及规模

阴道后脱垂发病率的上升将促进市场增长，人们生活方式的改变、体力劳动的减少以及政府对研发的支持增加是推动神经衰弱治疗市场发展的一些重要因素。许多神经衰弱患者的主要症状是身体和精神疲劳，劳累会加剧这种疲劳。他们通常有抑郁和焦虑的症状，但大多数情况下疲劳是主要症状。

Data Bridge Market Research 分析了 2023-2030 年预测期内神经衰弱治疗市场的增长率。神经衰弱治疗市场的预期复合年增长率在上述预测期内趋于 5.90% 左右。2022 年市场价值为 1 亿美元，到 2030 年将增长至 1.5819 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

神经衰弱治疗市场范围和细分

Market Definition

Neurasthenia is a neurological condition characterized by cell destruction that produces myelin. Myelin is a sticky material that supports nerve cells, in the brain and spinal cord, also known as white matter of the central nervous system. In healthy individuals, the JCV virus remains inactive leading to this dreadful disease only when the immune system is compromised. Major symptoms include problems with vision, balance, coordination, speech, and thinking.

Neurasthenia Treatment Market Dynamics

Drivers

• Increasing Prevalence of Fatigue

Fatigue is prevalent in the general population, but the diagnosis of neurasthenia is lesser. A study found that although 13% of the population complain of prolonged and excessive fatigue, but less than 2% met ICD-10 criteria for neurasthenia, and less than 0.5% neurasthenia without comorbid anxiety and depression. Neurasthenia is more common in women.

• Rising R&D Activities By Market Players

Growing emphasis on the R&D of drugs and therapies for rare diseases creates a huge opportunity for the market. Several companies are trying to innovative therapies aimed at control of the condition instead of improving immunity, projected to increase the growth of the neurasthenia treatment market during the forecast period.

Opportunities

• Varied Treatment Methods

There are various treatment processes that create many opportunities for the diseased condition. Several studies suggest that antidepressant treatments are of limited value, but there is good evidence for rehabilitative psychological treatments, including CBT and simple graded exercise therapy.

• Increasing Rates of Depression

About 17.3 million people were suffering from major depressive episodes in the U.S. during 2017 as per the records of the National Institute of mental health (NIMH). The occurrence rate is greater in adults aged 18 to 25 years. Therefore, with high-stress conditions because of several socioeconomic factors and significant spending ability within this range, the segment is expected to flourish considerably during the forecast period. 

Restraints/Challenges

• Unavailability of treatment options

Lack of specific treatments and therapies for neurasthenia treatment that do not lead to favorable outcomes is likely to hamper the market growth. The current neurasthenia treatment options focus on several therapies and antidepressants. Thus, specified treatment options that help the patients' exact improvement are necessary.

• Lack of patient awareness

Lack of awareness about anxiety can serve as a restraining factor for the market. Many people are not aware of the fact that they are suffering from anxiety or depression and tend to ignore it and thus as a result, the patients are deprived of the treatment process. This can hamper the market growth.

This neurasthenia treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neurasthenia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Neurasthenia Treatment Market Scope

The neurasthenia treatment market is segmented on the basis of symptoms, clinical feature, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Symptoms

• Depression
• Anxiety
• Others

Clinical Feature

• Physical
• Mental Fatigue

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Neurasthenia Treatment Market Regional Analysis/Insights

The neurasthenia treatment market is analyzed and market size insights and trends are provided by symptoms, clinical feature, distribution channel and end-user as referenced above.

The major countries covered in the neurasthenia treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to rise in the prevalence of the disease, rise in the healthcare affordability in the U.S. and rise in the knowledge and awareness amongst the people in this region

Asia-Pacific dominates the market due to an increased prevalence of fatigue and depression.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

竞争格局和全球神经衰弱治疗市场份额分析

神经衰弱治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对神经衰弱治疗市场的关注有关。

神经衰弱治疗市场的主要参与者包括：

• 强生服务公司（美国）
• COOPERSURGICAL, INC（美国）
• MEDGYN PRODUCTS, INC（美国）
• 托马斯医疗。（美国）
• 史密斯集团有限公司 (英国)
• 泛太医疗股份有限公司 (台湾)
• Personal Medical Corp.（美国）
• 波士顿科学公司 (美国)
• Coloplast Pvt. Ltd. (印度)
• 库克（美国）
• Integra LifeSciences（美国）
• medesign IC GmbH (德国)
• 美敦力（爱尔兰）

SKU-63567